Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
21.03
-0.33 (-1.54%)
Dec 26, 2025, 4:00 PM EST - Market closed
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $640.7 million as of December 26, 2025. Its market cap has decreased by -76.15% in one year.
Market Cap
640.70M
Enterprise Value
-35.34M
1-Year Change
-76.15%
Ranking
Category
Stock Price
$21.03
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $640.70M, an increase of 66.28%. That is a compound annual growth rate of 9.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 640.70M | -0.08% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | 1.64B | 324.32% |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |